Long Shortz with EBR Systems: FDA green lights Wise CRT system launch

EBR Systems has been given the go ahead from the FDA to launch its Wise CRT system for left ventricular pacing in the US.

Tylah Tully speaks with EBR Systems (ASX:EBR) CEO and President John McCutcheon to discuss the company's latest major milestone - securing FDA approval for the launch of its Wise CRT system in the United States. 

The approval enables EBR access into a multi-billion dollar market, with the Wise CRT system being the first and only leadless solution for left ventricular pacing.

Watch the video to hear more about how it works and whats next for EBR.

This video was developed in collaboration with EBR Systems, a Stockhead advertiser at the time of publishing. 

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Originally published as Long Shortz with EBR Systems: FDA green lights Wise CRT system launch